Page
%P
-
Article
Open AccessAn open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease
Preclinical data have shown that rilmenidine can regulate autophagy in models of Huntington’s disease (HD), providing a potential route to alter the disease course in patients. Consequently, a 2-year open-labe...
-
Article
Spinocerebellar ataxias caused by polyglutamine expansions: A review of therapeutic strategies
Six of the spinocerebellar ataxias (SCAs) are caused by expanded CAG trinucleotide repeats encoding polyglutamine tracts in different genes. Together with three other neurodegenerative diseases they represent ...